SK Biopharmaceuticals announced that the company has set its initial public offering (IPO) price at 49,000 won per share – the top end of its indicative price range – after orders from institutional investors on June 17 and 18.

The company had initially set the IPO price range of 36,000 won to 49,000 won per share.

As the share price has been determined at the top of the price band, the total public offering would be valued at 959.3 billion won, with the market capitalization reaching at around 3.8 trillion won.

A total of 1,076 domestic and foreign institutional investors have participated in the book building and made bids for 11.75 million shares, or 60 percent of the total. The subscription rate stood at 835.66:1.

Retail subscription will take place on June 23-24. The company plans to list its shares on the KOSPI on July 2.

Media Contact:

Hyongki Park (H. Park)

SK Biopharmaceuticals

skbp_comm@sk.com